Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement
NCT07663175
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
B-cell Lymphomas With MYC Rearrangement
Sponsor
IRCCS San Raffaele